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Abstract
Leishmania RNA Virus (LRV, Totiviridae) infect Leishmania cells and subvert mice immune re-
sponse, probably promoting parasite persistence, suggesting significant roles for LRV in
host-parasite interaction. Here we describe a new LRV1-4 purification protocol, enabling capsid vi-
sualization by negatively stained electron microscopy representing a significant contribution to fu-
ture LRV investigations.
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In 1960 the first protozoa virus was discovered in
Entamoeba histolytica, opening the possibility of investi-
gating similar virus in unicellular eukaryotes (Gupta and
Deep, 2007). Almost three decades later, in 1988, the first
Leishmania infecting virus was reported as a Leishmania
RNA virus or LRV (Tarr et al., 1988).
Leishmania RNA viruses are currently classified as
belonging to the Totiviridae family, composed of virus par-
ticles with capsids of approximately 40 nm in diameter and
a 5,280-nucleotide double-stranded RNA genome
(Schefter, 1994). LRV genome contains two open reading
frames encoding a capsid protein with endoribonuclease
activity and a RNA polymerase (Macabeth anda Patterson,
1995; Scheffter et al., 1995; Schefter, 1994; Suh, 1996).
Several aspects of leishmaniasis are still the subject
of intense investigation. Leishmaniasis is predominantly a
rural disease of serious public health concern affecting 88
countries on 4 continents with an estimated 1.6 million new
cases annually (WHO, 2010). One poorly understood as-
pect of the infection is the mechanisms involved in lesion
development in mucocutaneous leishmaniasis. However, it
has been shown that a strain of L. guyanensis infected with
LRV1-4 induced more metastasizing lesions in mice than a
virus-free one. These observations suggest that the pres-
ence of LRV1-4 rendered the animals more susceptible to
disseminated infection, perhaps enabling Leishmania to
subvert host immune response and promote parasite persis-
tence (Ives et al., 2011). This observation brings to light a
potential involvement of LRV in Leishmania pathogenesis.
However, to further advance the investigation of LRV1 in-
teraction with the parasite, it is paramount to obtain pure
LRV particles. Previous work has described the production
of “recombinant” LRV particles in Leishmania (Ro et al.,
2004) or baculovirus cells (Tamarra and Patterson, 2003).
These experiments greatly advanced the study of LRV,
however, as they result in empty capsid virions, since only
the capsid protein is introduced into de expression system, a
functional study of the virus is not possible. The seminal
work that established the existence of LRV (Tarr et al.,
1988) involved the isolation of native viral particles. Those
experiments resulted in cumbersome protocols and appar-
ently low virion yield. The LRV1-4 purification protocol
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presently reported enabled observation of LRV1-4 particles
associated with filaments associated with the capsid verti-
ces, suggesting extruded RNA.
LRV was purified from Leishmania (Viannia)
guyanensis strain MHOM/BR/75/M4147, hereby referred
to simply as M4147, which is infected with LRV1-4.
Promastigotes were maintained in medium M199 at 26 °C
supplemented with 10% heat inactivated fetal bovine se-
rum, 2% human male urine, 100 mM adenine, 10 mg/mL
hemin, 40 mM 4-(2-hydroxyethyl)-1-piperazine-
ethanesulfonic acid (HEPES, pH 7.4), 50 mg/mL penicillin
and 50 mg/mL streptomycin. Leishmania cells were grown
to a density of 105 parasites/mL, after which they were cen-
trifuged at 3000 x g for 10 min (4 °C) and suspended in
buffer A containing 10 mM Tris-HCl (pH7.5), 150 mM
NaCl, 10 mM DTT and 0.1% Triton X-100. The cell sus-
pension was lysed by sonication in a 550 Sonic Dismem-
brator (Fisher Scientific) and monitored by observation in
the microscope, then clarified by centrifugation at 3000 x g
for 10 min, filtered through a 22 m filter and subject to ul-
tracentrifugation in a 10% to 50% Opitiprep (Accurate
Chemical Corp.) step gradient of 400 L volume layers of
10% (1.06 g/mL density), 20% (1.11 g/mL density), 30%
(1.17 g/mL density), 40% (1.22 g/mL density) and 50%
(1.27 g/mL density) iodixanol in buffer A. The gradient
was centrifuged for 3 h at 350.000 x g at 4 °C and fraction-
ated in 10 fractions (200 L each) were separated from the
gradient. Gradient fractions were analyzed for LRV1-4
mRNA by semi-quantitative RT-PCR. The cDNA
synthesis was performed with RevertAid M-MuLV Re-
verse Transcriptase and 8 nucleotide long random primers
from total RNA isolated from each gradient fraction using
Trizol (Invitrogen) reagent following the manufacturer in-
structions. PCR amplification of the LRV1-4 specific
cDNA was accomplished with sequence-specific primers
(LRV1-4a 5’-ATGTGATGGCCCCGTGGTATTGG-3’
and LRV1-4b
5’-AACTCCGCCGGGTGAAACAGGTC-3’) in rounds
of 20, 25 or 30 amplification cycles, generating a PCR
product of 442 bp. The 25-cycle regimen resulted in the
best estimate of the RNA content, whereas 30 amplification
cycles resulted in the saturation of the signal for each
LRV1-4-containing sample, whereas 20 cycles resulted in
low signal, underestimating the amount of LRV1-4 RNA in
each fraction (Figure 1A). The presence of LRV1-4 spe-
cific RNA was detected in samples 2 to 7, and a higher con-
centration of the LRV1-4 RNA was observed in samples 3
to 5.
The iodixanol (Opitiprep) reagent was removed from
the samples by size exclusion chromatography. The gradi-
ent fraction 4 (Figure 1A) was loaded into a Superdex 200
HR 10/300 (GE) size exclusion column in buffer A at a
flow rate of 0.5 mL/min and monitored at 280 nm. The
LRV1-4 RNA was detected by RT-PCR in fraction 13 (Fig-
ure 1B). Samples of 1 mL were pooled together and con-
centrated in a 100 kDa concentrator.
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Figure 1 - LRV1-4 purification steps. A) Detection of LRV1-4 specific RNA fragment by RT-PCR in the gradient fractions 1 to 10. The semi-quantitative
amplification is shown by 20, 25 and 30 amplification cycles were the relative abundance of LRV1-4 is shown. B) Detection of LRV1-4 specific RNA
fragment by RT-PCR in the size-exclusion chromatography fractions 1 to 15. The virus is present only in fraction 13.
For LRV1-4 visualization by negative stain, the con-
centrated pooled sample in buffer A was deposited onto
holey carbon-coated grids, previously glow discharged for
25 s at 15 mA using an easiGlow system (PELCO). Sample
was deposited for 30 s, followed by two washing steps,
staining with 3 L of 2% uranyl acetate, blotting and
air-drying. Images were recorded close to focus at x60,000
magnification using a Jeol JEM-2100 operating at 200 kV.
The sample contained LRV1-4 icosahedral particles
in the size range expected for Totiviridae, with capsid di-
ameters ranging from 37 to 44 nm (Figure 2A and 2B). A
very faint RT-PCR amplification signal was detected in
fractions 3 to 5 which, upon negative stain analysis re-
vealed particles of about 25 nm diameter.
The smoother shape and reduced diameter (approxi-
mately 25 nm) of the particles in fractions 3-5 (Figure 2C)
could raise the possibility for the existence of less dense,
smaller capsid, perhaps even an inner shell that segregates
at a different gradient density range. However, other possi-
bilities exist, including the presence of unknown viruses
within Leishmania, and that these smaller particles and
their heterogeneous size distribution represent an artifact
not yet determined. Confirmation of the actual nature of
this finding awaits further studies. The yields of LRV1-4
cannot be estimated at this time, since comparison with pre-
vious work is not possible. The presently described purifi-
cation protocol will allow further investigation on the
structural organization and replication process of
Leishmania RNA viruses.
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